SCHEMBL4312450

SCHEMBL4312450

CNn1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088942 0.67
SCHEMBL1076627 0.62
SCHEMBL4723369 0.62
Dimethylamine SCHEMBL1760836 0.61
SCHEMBL3221482 0.61
SCHEMBL24501930 0.59
SCHEMBL28225821 0.53 INMT (0.39)
Benzene SCHEMBL27922842 0.52 TSHR (0.43)
Benzene SCHEMBL890697 0.52
Benzene SCHEMBL28192913 0.52 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1483320-A Heterocyclic ring contained methylamine cyanoacrylate compound and weeding activity 南开大学 2004-03-24 CN claimed
EP-3519411-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2022-06-22 EP disclosed
WO-2018174650-A9 PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES 재단법인 대구경북첨단의료산업진흥재단 2020-01-02 WO disclosed
CN-109293523-A A kind of ionic cross-linking monomer, Its Preparation Method And Use 世晟博(深圳)科技有限公司 2019-02-01 CN disclosed
WO-2018075479-A1 SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES MATERIA, INC. (US) 2018-04-26 WO disclosed
WO-2018060481-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2018-04-05 WO disclosed
EP-3301094-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS Mutabilis (FR) 2018-04-04 EP disclosed
CN-102118969-B Diaminopyridine, diaminopyrimidine and diaminopyridazine modulators of the histamine H4 receptor 詹森药业有限公司 2017-03-08 CN disclosed
EP-1322642-B1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of Protein Jun-kinases MERCK SERONO SA (CH) 2013-09-04 EP disclosed
US-8431695-B2 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-04-30 US disclosed
EP-0402752-A1 N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1990-12-19 EP disclosed
EP-0397040-A2 N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1990-11-14 EP disclosed
US-4916135-A ANALGESICS, ALZHEIMER*S HOECHST ROUSSEL PHARMACEUTICALS INC. (US) 1990-04-10 US disclosed
US-4914103-A ANALGESICS, ANTIINFLAMMATORY AGENTS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-04-03 US disclosed
US-4900742-A N-(pyrrol-1-yl)pyridinamine compounds having memory enhancing properties HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1990-02-13 US disclosed
EP-0352629-A2 Pyrido [3,4-f]pyrrolo[1,2-b][1,2,5]triazepines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1990-01-31 EP disclosed
US-4879382-A ANTIDEPRESSANT, ANALGESIC, ANTIINFLAMMATORY, MEMORY ENHANCER HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-11-07 US disclosed
US-4792562-A N-(pyrrol-1-yl)pyridinamines having memory enhancing activity HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1988-12-20 US disclosed
US-4752610-A N-(pyrrol-1-yl)pyridinamines having memory enhancing properties HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-06-21 US disclosed
EP-0226099-A2 N-(pyrrol-1-yl)pyridinamines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1987-06-24 EP disclosed